Phase II clinical trial of S-1 plus nanoparticle albumin-bound paclitaxel as first-line chemotherapy for patients with metastatic gastric cancer

被引：0
|
作者：
Xu, Rui-hua
He, Ming-ming
Zhang, Dong-sheng
Wang, Feng
Jin, Ying
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.4049
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4049
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Multicentric phase II trial of gemcitabine plus epirubicin plus paclitaxel as first-line chemotherapy in metastatic breast cancer
    Cappuzzo, F
    Mazzoni, F
    Gennari, A
    Donati, S
    Salvadori, B
    Orlandini, C
    Cetto, GL
    Molino, A
    Galligioni, E
    Mansutti, M
    Tumolo, S
    Lucentini, A
    Valduga, F
    Bartolini, S
    Crinò, L
    Conte, PF
    BRITISH JOURNAL OF CANCER, 2004, 90 (01) : 31 - 35
  • [22] A phase II study of biweekly oxaliplatin plus S-1 combination chemotherapy as a first-line treatment for patients with metastatic or advanced gastric cancer in China
    Xiao, Cheng
    Qian, Jiong
    Zheng, Yulong
    Song, Fang
    Wang, Qiangfeng
    Jiang, Haiping
    Mao, Chenyu
    Xu, Nong
    MEDICINE, 2019, 98 (20)
  • [23] Addition of sintilimab to nanoparticle albumin-bound paclitaxel and S-1 as adjuvant therapy in stage IIIC gastric cancer
    Mei, Yu
    Shi, Min
    Zhu, Zhenglun
    Yuan, Hong
    Yan, Chao
    Li, Chen
    Feng, Tienan
    Yan, Min
    Zhang, Jun
    Zhu, Zhenggang
    FUTURE ONCOLOGY, 2021, 18 (02) : 139 - 148
  • [24] A phase II study of weekly nanoparticle albumin-bound paclitaxel combined with cisplatin in patients with metastatic breast cancer
    Wang, Biyun
    Hu, Xi-Chun
    Sun, Si
    Zhang, Jian
    Tang, Lichen
    Wang, Zhong Hua
    Wang, Lei Ping
    Lv, Fangfang
    Zhang, Qunling
    Zheng, Chunlei
    Jia, Zhen
    Lu, Yunhua
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [25] Randomized phase II trial of nanoparticle albumin-bound paclitaxel in three dosing schedules with bevacizumab as first-line therapy for HER2-negative metastatic breast cancer (MBC)
    Conlin, A. K.
    Hudis, C. A.
    Bach, A.
    Moynahan, M.
    Lake, D.
    Forero-Torres, A.
    Wright, G.
    Hackney, M.
    Clawson, A.
    Seidman, A. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [26] Randomized Phase II Trial of Weekly vs. Every 2 Weeks vs. Every 3 Weeks Nanoparticle Albumin-Bound Paclitaxel With Bevacizumab as First-Line Chemotherapy for Metastatic Breast Cancer
    Seidman, Andrew D.
    Conlin, Alison K.
    Bach, Ariadne
    Moynahan, Mary Ellen
    Lake, Diana
    Forero, Andres
    Wright, Gail Shaw
    Hackney, Mary Helen
    Clawson, Alicia
    Norton, Larry
    Hudis, Clifford A.
    CLINICAL BREAST CANCER, 2013, 13 (04) : 239 - +
  • [27] A multicenter randomized phase III study of albumin-bound paclitaxel combined with S-1 (AS) versus oxaliplatin combined with S-1 (SOX) for first-line treatment of advanced gastric cancer (GAPSO study)
    Dai, Yuhong
    Yu, Xiongjie
    Xu, Huiting
    Zhuang, Liang
    Zhang, Mingsheng
    Zou, Yanmei
    Fu, Qiang
    Qiu, Hong
    Yuan, Xianglin
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [28] A RANDOMIZED PHASE II TRIAL OF BIWEEKLY S-1 WITH PACLITAXEL (SPA) OR OXALIPLATIN (SOX) AS FIRST-LINE CHEMOTHERAPY IN ADVANCED GASTRIC CANCER PATIENTS: PRELIMINARY RESULTS
    Haibo, M.
    Fang, W.
    Zheng, Y.
    Zhao, P.
    Mao, C.
    Zhang, X.
    Qian, J.
    Jiang, H.
    Zheng, Y.
    Xu, N.
    ANNALS OF ONCOLOGY, 2012, 23 : 256 - 256
  • [29] Nanoparticle albumin-bound paclitaxel combined with cisplatin as the first-line treatment for metastatic esophageal squamous cell carcinoma
    Shi, Yan
    Qin, Rui
    Wang, Zhi-Kuan
    Dai, Guang-Hai
    ONCOTARGETS AND THERAPY, 2013, 6 : 585 - 591
  • [30] A PHASE II STUDY OF S-1 AND OXALIPLATIN AS FIRST-LINE THERAPY FOR PATIENTS WITH RECURRENT OR METASTATIC GASTRIC CANCER
    Kim, H. G.
    Kang, M.
    Kim, S.
    Lee, S. I.
    Lee, G.
    Kang, J. H.
    ANNALS OF ONCOLOGY, 2008, 19 : 182 - 182
12345